agilon health, inc.

AGL's RSI of 77.6 signals extreme overbought conditions—a level rarely sustainable without pullback risk. Trading well below its 52-week high despite this momentum spike suggests the stock has already corrected from even greater heights, raising questions about whether the current rally represents genuine strength or a dead-cat bounce in a healthcare services name with just $0.9B market cap. The 9.63% short interest is modest, so squeeze mechanics aren't driving this move. The absence of a P/E ratio indicates unprofitability, making this a speculative turnaround play where technical exhaustion could trigger sharp mean reversion.